Irinotecan Kabi 20 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinotecan kabi 20 mg/ml inf. sol. (conc.) i.v. vial

fresenius kabi sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - 20 mg/ml - irinotecan hydrochloride trihydrate 20 mg/ml - irinotecan

IRINOTECAN KABI irinotecan hydrochloride trihydrate 500mg/25mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan kabi irinotecan hydrochloride trihydrate 500mg/25ml concentrated injection vial

fresenius kabi australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 500 mg - injection, concentrated - excipient ingredients: sorbitol; lactic acid; sodium hydroxide; water for injections - irinotecan injection is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN KABI irinotecan hydrochloride trihydrate 300mg/15mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan kabi irinotecan hydrochloride trihydrate 300mg/15ml concentrated injection vial

fresenius kabi australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 300 mg - injection, concentrated - excipient ingredients: sorbitol; lactic acid; sodium hydroxide; water for injections - irinotecan injection is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN KABI irinotecan hydrochloride trihydrate 40 mg/2 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan kabi irinotecan hydrochloride trihydrate 40 mg/2 ml concentrated injection vial

fresenius kabi australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 40 mg - injection, concentrated - excipient ingredients: lactic acid; sorbitol; sodium hydroxide; water for injections - irinotecan injection is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN KABI irinotecan hydrochloride trihydrate 100 mg/5 mL concentrated injection vial Australia - English - Department of Health (Therapeutic Goods Administration)

irinotecan kabi irinotecan hydrochloride trihydrate 100 mg/5 ml concentrated injection vial

fresenius kabi australia pty ltd - irinotecan hydrochloride trihydrate, quantity: 100 mg - injection, concentrated - excipient ingredients: water for injections; lactic acid; sodium hydroxide; sorbitol - irinotecan injection is indicated for patients with metastatic carcinoma of the colon or rectum whose disease has recurred or progressed following initial therapy.

IRINOTECAN HYDROCHLORIDE TRIHYDRATE FOR INJECTION SOLUTION Canada - English - Health Canada

irinotecan hydrochloride trihydrate for injection solution

fresenius kabi canada ltd - irinotecan hydrochloride (irinotecan hydrochloride trihydrate) - solution - 20mg - irinotecan hydrochloride (irinotecan hydrochloride trihydrate) 20mg - antineoplastic agents

Oxaliplatin 5 mg/ml concentrate for solution for infusion Ireland - English - HPRA (Health Products Regulatory Authority)

oxaliplatin 5 mg/ml concentrate for solution for infusion

fresenius kabi deutschland gmbh - oxaliplatin - concentrate for solution for infusion - 5 milligram(s)/millilitre - platinum compounds; oxaliplatin

Irinokabi 20 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinokabi 20 mg/ml inf. sol. (conc.) i.v. vial

fresenius kabi sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - irinotecan

Irinokabi 20 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinokabi 20 mg/ml inf. sol. (conc.) i.v. vial

fresenius kabi sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - irinotecan

Irinokabi 20 mg/ml inf. sol. (conc.) i.v. vial Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

irinokabi 20 mg/ml inf. sol. (conc.) i.v. vial

fresenius kabi sa-nv - irinotecan hydrochloride trihydrate 20 mg/ml - eq. irinotecan 17,33 mg/ml - concentrate for solution for infusion - irinotecan